Skip to main content
OpenTrials

Clinical trial condition

Metastatic Castration Sensitive Prostate Cancer (mCSPC)

Explore clinical trials studying Metastatic Castration Sensitive Prostate Cancer (mCSPC). Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Metastatic Castration Sensitive Prostate Cancer (mCSPC) trial results

Recruiting

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

NCT07028853

Conditions
Cancer of the Prostate, Genital Diseases, Genital Diseases, Male, +11 more
Locations
  • Clearview Cancer Institute (Crestwood) Huntsville, Alabama, United States
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Gilbert, Arizona, United States
View all 341 locations
View Trial Details

Related conditions